SS 07 - GYN 3: Quest for Prognostic and Predictive Biomarkers in Gynecological Malignancies

Moderator(s)

• 

  Michelle Ludwig, MD, PhD, MPH

  Baylor College of Medicine
  Houston, TX
• 

  Craig Grossman, MD, PhD, MS

  University of South Florida Morsani College of Medicine
  Tampa, FL

Presentations:

• 2:45 PM – 2:55 PM ET

  Examining the Impact of Combined P53 Status and PD-L1 Expression on Vulvar Cancer Outcomes
  

  Presenter: Baher Elgohari, MD, MS, MBBS – UPMC Hillman Cancer Center
• 2:55 PM – 3:05 PM ET

  The Prognostic Impact of MLH1 Promoter Hypermethylation in Stage I-II Endometrial Cancer Treated with Adjuvant Radiotherapy
  

  Presenter: Zohaib Sherwani, MD – Rutgers Cancer Institute of New Jersey
• 3:05 PM – 3:15 PM ET

  The Prognostic Value of Pretreatment Carbohydrate Antigen 125 Level in Cervical Cancer Patients Treated with Definitive Radiotherapy or Concurrent Chemoradiotherapy
  

  Presenter: Dingchao Liu, MD – Peking Union Medical College Hospital
• 3:15 PM – 3:25 PM ET

  Longitudinal Dynamic MRI Radiomic Models for Early Prediction of Prognosis in Locally Advanced Cervical Cancer Treated with Concurrent Chemoradiotherapy
  

  Presenter: Chang Cai, BS
• 3:25 PM – 3:35 PM ET

  Incidence of Cervical Cancer Subtypes in Relation to HPV Vaccination Uptake in the U.S.
  

  Presenter: Peter Lee, MD, PhD – Fox Chase Cancer Center
• 3:35 PM – 3:45 PM ET

  Effect of Cisplatin Cycles on Prognosis for Locally Advanced Cervical Cancer Patients Treated with Concurrent Chemoradiotherapy: A Long-Term Follow-Up, Large Cohort Study
  

  Presenter: Zheng Zeng, MD – Peking Union Medical College Hospital
• 3:45 PM – 3:55 PM ET

  Discussant
  

  Discussant: Eric Donnelly, MD – Northwestern Memorial Hospital